Ranjini Sankaranarayanan

Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer

Rakesh Dachineni, Dileep Kumar, Eduardo Callegari et al. · International Journal of Oncology · 2017 · 88 citations · Full text

Anti-inflammatory, Cdk1 Enzyme Activity, Biochemistry +12

The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention

Ranjini Sankaranarayanan, Chaitanya K. Valiveti, Dinesh Kumar et al. · Cancers · 2019 · 77 citations · Full text

Screening of Human Gut Bacterial Culture Collection Identifies Species That Biotransform Quercetin into Metabolites with Anticancer Properties

Ranjini Sankaranarayanan, Prabhjot Kaur Sekhon, Achuthan Ambat et al. · International Journal of Molecular Sciences · 2021 · 38 citations · Full text

Aspirin metabolites 2,3‑DHBA and 2,5‑DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention

Ranjini Sankaranarayanan, Chaitanya K. Valiveti, Rakesh Dachineni et al. · Molecular Medicine Reports · 2019 · 28 citations · Full text

Molecular Pharmacology, Chemoprevention Strategy, Medicine +13

Synthesis of 3-(2-pyridyl)-2-substituted-quinazolin-4(3H)-ones as new analgesic and anti-inflammatory agents

V. Alagarsamy, V. Raja Solomon, M. Murugan et al. · Biomedicine & Pharmacotherapy · 2006 · 15 citations

Medicinal Chemistry, Anti-inflammatory Agents, Medicine +3